← Back to All Filings

UNH Director Receives Minor Dividend Equivalent Grant

Low SignificanceDecember 18, 2025 at 5:36:44 PM EST

UNITEDHEALTH GROUP INC

$UNH4CIK: 0000731766

Subscribe to track UNH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

UNH Director Receives Minor Dividend Equivalent Grant

Company: UNITEDHEALTH GROUP INC (UNH) Form: 4 | Filed: 2025/12/18 Significance: Low

Insider: MCNABB FREDERICK WILLIAM III Title: null | Relationship: Director

Transaction: • Type: Grant • Shares: 53 • Price: $0.00 • Value: $0 • Owned After: 14,394

Key Insight: This is a routine, non-cash award of dividend equivalents on existing deferred stock units, representing a negligible change in ownership.

Market Context: The transaction value is $0 and involves an insignificant number of shares relative to UnitedHealth's $291.55B market cap.

Comprehensive Analysis

SEC Filing Analysis: UNITEDHEALTH GROUP INC (UNH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director received a minor, non-discretionary grant of 53 shares as dividend equivalents on existing stock units, a routine event with no market impact.
  • Market Impact: Neutral. The transaction is too small to influence the market or investor sentiment.

Company Information

FieldValue
CompanyUNITEDHEALTH GROUP INC
Ticker SymbolUNH
CIK0000731766
IndustryHospital & Medical Service Plans

Insider Information

FieldValue
NameMCNABB FREDERICK WILLIAM III
CIK0001731814
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-16
Transaction CodeA (Award)
Security TypeCommon Stock
Shares Involved53
Price Per Share$0.00
Total Value$0
Shares Owned After14,394
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted53
% of Shares Outstanding0.000006%
Post-Transaction Ownership14,394 shares (0.0016% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $291.55 billion, this $0 transaction is financially immaterial.
  • Ownership Concentration: The director's post-transaction ownership of 14,394 shares constitutes a negligible 0.0016% of total shares outstanding, indicating very low ownership concentration.
  • Dilution Impact: The issuance of 53 new shares has a zero practical dilution impact on existing shareholders.
  • Transaction Significance: The transaction is classified as low significance due to its zero value and minuscule size relative to both market cap and shares outstanding. It is a routine administrative action.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a non-discretionary award of dividend equivalents with a total value of $0. It does not signal any change in insider sentiment or company fundamentals.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction is too small to affect trading volume.
  • Sentiment Indicator: Neutral. This is a routine filing that will be disregarded by the market.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnote clarifies that these shares are dividend equivalents paid on vested deferred stock units. This is a standard, automated part of director compensation and not an active investment decision.
Topics:#SECFiling#InsiderTransactions#UNH#UnitedHealthGroup#Form4#StockMarket#Investing#FinancialData

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.